NEURALY
Neuraly, a startup biotech company, was formed in 2016 following foundational research by world class neuroscientists led by Ted Dawson, M.D., Ph.D., Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases and Director of the Institute for Cell Engineering at the Johns Hopkins School of Medicine. Following the acquisition of exclusive licenses to patents covering the composition of matter and methods of use, research supporting the development of NLY01 was recently published in Nature Medicine1. These data demonstrated the critical role of the glial compartment of the neural tissue in the pathogenesis of neurodegenerative diseases such as Parkinson's and Alzheimer's diseases.
NEURALY
Social Links:
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Germantown, Maryland, United States
Country:
United States
Website Url:
http://www.neuralymed.com
Total Employee:
11+
Status:
Active
Total Funding:
36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Current Advisors List
Current Employees Featured
Founder
Investors List
Smilegate Investment
Smilegate Investment investment in Series A - Neuraly
Octave Life Sciences
Octave Life Sciences investment in Series A - Neuraly
D&D Pharmatech
D&D Pharmatech investment in Series A - Neuraly
LB Investment
LB Investment investment in Series A - Neuraly
Maryland Venture Fund
Maryland Venture Fund investment in Series A - Neuraly
Magna Investment
Magna Investment investment in Series A - Neuraly
InterVest
InterVest investment in Series A - Neuraly
Dongkoo Bio&Pharma
Dongkoo Bio&Pharma investment in Series A - Neuraly
Geon Investment
Geon Investment investment in Series A - Neuraly
Boston Harbor Angels
Boston Harbor Angels investment in Angel Round - Neuraly
Official Site Inspections
http://www.neuralymed.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Neuraly"
Neuraly
Mar 27, 2023 · Neuraly was founded to develop new drugs that change our expectations about successful treatment of progressive diseases like Alzheimer’s and Parkinson’s. We are …See details»
About - Neuraly
Neuraly is a clinical-stage biotechnology company whose mission is to translate scientific discoveries in neurology into new drugs that can radically improve and prolong the lives of …See details»
Team — Neuraly
Dr. Roschke, co-founder, is Chief Scientific Officer and Head of Research and Development. He has more than 20 years of experience in drug development as senior executive in …See details»
Neuraly Company Profile 2024: Valuation, Investors, …
Operator of a clinical-stage biotechnology company intended to translate scientific discoveries in neurology into new drugs.See details»
Neuraly Inc. - LinkedIn
Neuraly is a clinical-stage company whose mission is to discover and develop scientific discoveries in neurology into revolutionary new drugs that can radically improve and prolong the lives of...See details»
Neuraly - Crunchbase Company Profile & Funding
Neuraly, a startup biotech company, was formed in 2016 following foundational research by world class neuroscientists led by Ted Dawson, M.D., Ph.D., Leonard and Madlyn Abramson …See details»
Neuraly (USA) Funding: $36M - medicalstartups.org
Nov 7, 2024 · Website: http://www.neuralymed.com/ Neuraly is a Johns Hopkins School of Medicine spinoff biotech company and aims to introduce the first, disease-modifying agent for …See details»
Neuraly - workinbiotech.com
Neuraly is a clinical-stage biotechnology company focused on developing disease-modifying agents for neurodegenerative disorders. Their focus is on the glial and microglial cells of the …See details»
Neuraly - VentureRadar
Website: http://www.neuralymed.com/ Develops neuroprotective agents for neurological disorders, including Alzheimer's and Parkinson's, with a pipeline of early-stage candidates …See details»
Neuraly Announces Completion of Enrollment in Phase …
Apr 19, 2022 · GAITHERSBURG, Md.-- ( BUSINESS WIRE )--Neuraly, a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced the completion of patient...See details»
Science — Neuraly
Activation of glial cells in neural tissue plays a critical role in pathogenesis of neurodegenerative diseases. To date, there are no disease-modifying therapies that reverse, stop or slow the relentless neurodegeneration in Parkinson’s …See details»
Neuraly Inc.: Contact Details and Business Profile
Neuraly Inc. is a Pharmaceutical Manufacturing, Biotechnology, and Science and Engineering company_reader located in Gaithersburg, Maryland with 21 employees. Find top employees, …See details»
Neuraly - Overview, News & Similar companies | ZoomInfo.com
Apr 19, 2022 · View Neuraly (www.neuralymed.com) location in Maryland, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Neuraly Announces Topline Results from Phase 2 Trial of NLY01 in ...
Mar 27, 2023 · GAITHERSBURG, Md.-- (BUSINESS WIRE)--Neuraly, a clinical-stage biotechnology company pioneering development of disease-modifying agents for …See details»
Neuraly Company Profile - Office Locations, Competitors ... - Craft
Neuraly is a clinical-stage biotechnology company that specializes in the development of drugs for neurodegenerative diseases. It offers treatments for Parkinson’s disease (PD), Alzheimer’s …See details»
News — Neuraly
Ten Johns Hopkins University faculty members have been elected to the National Academy of Medicine, an independent organization of leading professionals from diverse fields, including …See details»
Neuraly Announces Publication in Acta Neuropathologica …
Apr 28, 2021 · Neuraly is a clinical-stage company whose mission is to translate scientific discoveries in neurology into revolutionary new drugs that can radically improve and prolong …See details»
Co-Founder & CSO Board of Directors at Neuraly - ZoomInfo
Who is Neuraly’s Co-Founder & CSO Board of Directors? Get the details of Viktor Roschke's business profile including email address, phone number, work history and more.See details»
Viktor Roschke Email & Phone Number - RocketReach
Get Viktor Roschke's email address (v*****@neuralymed.com) and phone number (301502....) at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for 450M+ …See details»
Pipeline — Neuraly
NLY01 penetrates the blood–brain barrier (BBB) and its receptor (GLP-1R) is highly expressed on glial cells in Parkinson’s disease (PD) and Alzheimer’s disease (AD). The neuroprotective …See details»